Cancer Letters

SJR Rank #688H-index: 240SJR: 3.066Best quartile: Q1APC: US$4,960
Journal website: aims, scope and author guidelines
Publisher

Elsevier Ireland Ltd

Country

Ireland

Type

journal

SJR by Edition

2022202500.81.62.43.2

Subject Categories

  • Cancer ResearchQ1
  • OncologyQ1

Areas: Biochemistry, Genetics and Molecular Biology · Medicine

Most published research topics

Cancer, Hypoxia, and MetabolismCancer-related Molecular PathwaysDiverse Scientific and Economic StudiesHuman auditory perception and evaluationRNA modifications and cancerCarcinogens and Genotoxicity AssessmentCancer Cells and MetastasisEducational Robotics and EngineeringEpigenetics and DNA MethylationCancer-related molecular mechanisms research

Source: OpenAlex

Publication Statistics

2025 Docs3-Year DocsCitable Docs035070010501400

Documents per Year

202220250150300450600

Detailed Information

ISSN

0304-3835, 1872-7980

SJR Best Quartile

Q1

Region

Western Europe

Citations per Document (2 years)

11.29

References per Document

75.89

Coverage

1975-2026

Scope

CANCER LETTERS is a journal providing rapid publication of full-length articles in the broad area of cancer research. The journal places emphasis on the molecular and cell biology of cancer, oncogenes, carcinogenesis, radiation biology, molecular pathology, hormones and cancer, viral oncology, biology of cancer and metastasis, molecular cytogenetics, epidemiology; and experimental therapeutics. The primary criterion for publication is interest to a multidisciplinary audience. Papers should be technically sound and substantiated by sufficient experimental detail. Clinical papers will be accepted if they contribute to the understanding of the basic mechanisms underlying disease.

Metrics from SCImago Journal Rank 2025. View on SCImago